Cargando…
Blockade of miR-140-3p prevents functional deterioration in afterload-enhanced engineered heart tissue
Afterload enhancement (AE) of rat engineered heart tissue (EHT) in vitro leads to a multitude of changes that in vivo are referred to as pathological cardiac hypertrophy: e.g., cardiomyocyte hypertrophy, contractile dysfunction, reactivation of fetal genes and fibrotic changes. Moreover AE induced t...
Autores principales: | Werner, Tessa R., Kunze, Ann-Cathrin, Stenzig, Justus, Eschenhagen, Thomas, Hirt, Marc N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686025/ https://www.ncbi.nlm.nih.gov/pubmed/31391475 http://dx.doi.org/10.1038/s41598-019-46818-0 |
Ejemplares similares
-
Recapitulation of dyssynchrony-associated contractile impairment in asymmetrically paced engineered heart tissue
por: Stenzig, Justus, et al.
Publicado: (2022) -
Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue
por: Jacob, Fabian, et al.
Publicado: (2016) -
Correction: Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue
por: Jacob, Fabian, et al.
Publicado: (2018) -
Increased afterload induces pathological cardiac hypertrophy: a new in vitro model
por: Hirt, Marc N., et al.
Publicado: (2012) -
Effects of the Delta Opioid Receptor Agonist DADLE in a Novel Hypoxia-Reoxygenation Model on Human and Rat-Engineered Heart Tissue: A Pilot Study
por: Funcke, Sandra, et al.
Publicado: (2020)